Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Risk of Hemorrhage in Patients with Polycythemia Vera Exposed to Aspirin in Combination with Anticoagulants: Results of a Prospective, Multicenter, Observational Cohort Study (REVEAL)

Jeffrey I. Zwicker, MD, David S. Lessen, MD, Philomena Colucci, DO, MS, Dilan Paranagama, PhD, Michael R. Grunwald, MD

Blood (2019) 134 (Supplement_1): 168.

https://doi.org/10.1182/blood-2019-123835

Published: 2019

Journal Articles

Disease Characteristics of Minority Patient Populations with Polycythemia Vera: An Analysis from the Reveal Study

Ivy Altomare, MD, Philomena Colucci, DO, MS, Shreekant Parasuraman, BPharm, PhD, Dilan Chamikara Paranagama, PhD, Anas Al-Janadi, MD

Blood (2018) 132 (Supplement 1): 4735.

https://doi.org/10.1182/blood-2018-99-112530

Published: 2018

Journal Articles

Correlation between MPN-SAF TSS and EORTC QLQ-C30 Scores in Patients with PV: Data from the Reveal Study

Ivy Altomare, MD, Aaron T. Gerds, MDMS, David Lessen, MD, Philomena Colucci, DO, MS, Shreekant Parasuraman, BPharm, PhD, Dilan Chamikara Paranagama, PhD, Ruben A. Mesa, MD FACP

Blood (2018) 132 (Supplement 1): 2259.

https://doi.org/10.1182/blood-2018-99-112937

Published: 2018

Journal Articles

Patient-Reported Symptom Burden and Peripheral Blood Counts Among Patients with Polycythemia Vera: An Analysis from the Reveal Study

Michael Richard Grunwald, MD, John M. Burke, MD, David J Kuter, MD DPhil, Aaron T. Gerds, MDMS, Brady Lee Stein, MD MHS, Michael R. Savona, MD, Mark A. Walshauser, MD, Ahmad B. Naim, MD, Philomena Colucci, DO, MS, Dilan Chamikara Paranagama, PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 2924.

https://doi.org/10.1182/blood.V130.Suppl_1.2924.2924

Published: 2017

Journal Articles

Examining the Treatment Patterns and Blood Counts Among Patients with Polycythemia Vera Treated with Hydroxyurea in the United States: An Analysis from the Reveal Study

Michael Richard Grunwald, MD, Ivy Altomare, MD, John M. Burke, MD, Aaron T. Gerds, MDMS, Mark A. Walshauser, MD, Michael R. Savona, MD, David J Kuter, MD DPhil, Brady Lee Stein, MD MHS, Stephen Oh, MD PhD, Philomena Colucci, DO, MS, Ahmad B. Naim, MD, Dilan Chamikara Paranagama, PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 1633.

https://doi.org/10.1182/blood.V130.Suppl_1.1633.1633

Published: 2017

Journal Articles

Examining the Frequency of Phlebotomy in Patients with Polycythemia Vera (PV) in the United States: An Analysis of Data from the REVEAL Study

Ralph V. Boccia, MD, Pedro M. Sanz-Altamira, MD, Khuda Dad Khan, MD PhD, Dmitriy Berenzon, MD, Ellen W. Friedman, MD, Ahmad B. Naim, MD, Dilan Chamikara Paranagama, PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 5271.

https://doi.org/10.1182/blood.V130.Suppl_1.5271.5271

Published: 2017

Journal Articles

Examining the Clinical Features and Underlying Cardiovascular Risk Among Patients with Polycythemia Vera in the REVEAL Study

Brady L. Stein, MD, Ahmad Naim, MD, Michael R. Grunwald, MD, Alison R. Moliterno, MD, Stephen T. Oh, MD PhD, Dilan Paranagama, PhD, Joseph A. Cordaro, PharmD, MBA, Hao Sun, MS, Shreekant Parasuraman, BPharm, PhD, Ralph V. Boccia, Ruben Mesa, MD FACP

Blood (2016) 128 (22): 1934.

https://doi.org/10.1182/blood.V128.22.1934.1934

Published: 2016

Journal Articles

Disease and Clinical Characteristics of Patients with Polycythemia Vera: An Early View of the Reveal Study

Brady Stein, MD, Alison Moliterno, MD, Ralph V. Boccia, MD, Ahmad B. Naim, MD, Joseph A. Cordaro, PharmD,MBA, Wei Peng, PhD, Hao Sun, MS, Shreekant V. Parasuraman, PhD, Ruben A. Mesa

Blood (2015) 126 (23): 2813.

https://doi.org/10.1182/blood.V126.23.2813.2813

Published: 2015

Journal Articles

Burden of Phlebotomy in Patients with Polycythemia Vera in the United States: Baseline Data from the REVEAL Study

Ralph V. Boccia, MD, Brady Stein, MD, Ruben A. Mesa, Ahmad B. Naim, MD, Joseph A. Cordaro, PharmD,MBA, Wei Peng, PhD, Hao Sun, MS, Shreekant V. Parasuraman, PhD, Alison Moliterno, MD

Blood (2015) 126 (23): 5187.

https://doi.org/10.1182/blood.V126.23.5187.5187

Published: 2015

Journal Articles

Self-Reported Quality-of-Life Impairment and Productivity Loss in Patients with Polycythemia Vera: Early Patient-Reported Outcomes Assessment from the REVEAL Study

Ruben A. Mesa, Ralph V. Boccia, MD, Alison Moliterno, MD, Ahmad B. Naim, MD, Joseph A. Cordaro, PharmD,MBA, Wei Peng, PhD, Hao Sun, MS, Shreekant V. Parasuraman, PhD, Brady Stein, MD

Blood (2015) 126 (23): 4084.

https://doi.org/10.1182/blood.V126.23.4084.4084

Published: 2015

Journal Articles

Evaluation of MMR Concordance Based on Either International Scale (IS) or National Comprehensive Cancer Network (NCCN) Criteria Using Reconstructed “Virtual” CML Patient Profiles From the REVEAL BCR-ABL Methods Comparison Study,

Poluru L. Reddy, PhD, DABCC, Paul Choppa, Mike M. Moradian, PhD, Nicholas T. Potter, PhD, FACMG, Michael M. Quigley, MD, Christopher D. Watt, MD, PhD, Holger Höfling, PhD, Brian Manning, PharmD, Andre Mignault, MS, Brian Mullaney, MD, PhD, Diego Ossa, MD, MSc, Andrew Stein, PhD, Sha-Sha Wang, PhD, Feng Yang, PhD, Meir Wetzler, MD

Blood (2011) 118 (21): 3542.

https://doi.org/10.1182/blood.V118.21.3542.3542

Published: 2011

Journal Articles

Lenalidomide Administration in Heavily Pretreated Patients with Non Hodgkin Lymphoma – First Report of the REVEAL Study (REVlimid® Effectiveness of Administration in patients with Lymphoma)

Luigi Rigacci, Francesco Zaja, Alberto Fabbri, Alice Di Rocco, MD, Angelo Michele Carella, MD, Liliana Devizzi, MD, Umberto Vitolo, MD, Pier Luigi Zinzani, MD, PhD, Sante Tura, MD

Blood (2011) 118 (21): 4979.

https://doi.org/10.1182/blood.V118.21.4979.4979

Published: 2011

NARROW

Risk of Hemorrhage in Patients with Polycythemia Vera Exposed to Aspirin in Combination with Anticoagulants: Results of a Prospective, Multicenter, Observational Cohort Study (REVEAL)

Disease Characteristics of Minority Patient Populations with Polycythemia Vera: An Analysis from the Reveal Study

Correlation between MPN-SAF TSS and EORTC QLQ-C30 Scores in Patients with PV: Data from the Reveal Study

Patient-Reported Symptom Burden and Peripheral Blood Counts Among Patients with Polycythemia Vera: An Analysis from the Reveal Study

Examining the Treatment Patterns and Blood Counts Among Patients with Polycythemia Vera Treated with Hydroxyurea in the United States: An Analysis from the Reveal Study

Examining the Frequency of Phlebotomy in Patients with Polycythemia Vera (PV) in the United States: An Analysis of Data from the REVEAL Study

Examining the Clinical Features and Underlying Cardiovascular Risk Among Patients with Polycythemia Vera in the REVEAL Study

Disease and Clinical Characteristics of Patients with Polycythemia Vera: An Early View of the Reveal Study

Burden of Phlebotomy in Patients with Polycythemia Vera in the United States: Baseline Data from the REVEAL Study

Self-Reported Quality-of-Life Impairment and Productivity Loss in Patients with Polycythemia Vera: Early Patient-Reported Outcomes Assessment from the REVEAL Study

Evaluation of MMR Concordance Based on Either International Scale (IS) or National Comprehensive Cancer Network (NCCN) Criteria Using Reconstructed “Virtual” CML Patient Profiles From the REVEAL BCR-ABL Methods Comparison Study,

Lenalidomide Administration in Heavily Pretreated Patients with Non Hodgkin Lymphoma – First Report of the REVEAL Study (REVlimid® Effectiveness of Administration in patients with Lymphoma)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only